Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

Kidney International

Volumn 67, Issue 1, 2005, Pages 237-247

  Sánchez Lozada, Laura G ^a   Tapia, Edilia ^a   Santamaría, José ^a   Avila Casado, Carmen ^a   Soto, Virgilia ^a   Nepomuceno, Tomás ^a   Rodríguez Iturbe, Bernardo ^a   Johnson, Richard J ^a   Herrera Acosta, Jaime ^a  

^a INC Ignacio Chavez ^*

Author keywords

Arteriolopathy; Cortical vasoconstriction; Glomerular hypertension; Hyperuricemia

Indexed keywords

ALLOPURINOL; CD5 ANTIGEN; OXONIC ACID; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERIOLOSCLEROSIS; ARTICLE; CONTROLLED STUDY; GLOMERULAR DYSFUNCTION; GLOMERULAR STRUCTURE; HYPERURICEMIA; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

EID: 10944243094     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00074.x     Document Type: Article

References (38)

1. CANNON PJ, STASON WB, DEMARTINI FE, et al: Hyperuricemia in primary and renal hypertension. N Engl J Med 275:457-464, 1966
2. DUNCAN H, DIXON AS: Gout, familial hypericaemia, and renal disease. Q J Med 29:127-135, 1960
3. MCBRIDE MB, RIGDEN S, HAYCOCK GB, et al: Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children. Pediatr Nephrol 12:357-364, 1998
4. NEAL DA, TOM BD, GIMSON AE, et al: Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 72:1689-1691, 2001.
5. OHNO I, HOSOYA T, GOMI H, et al: Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87:333-339, 2001
6. SYRJANEN J, MUSTONEN J, PASTERNACK A: Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15:34-42, 2000
7. ISEKI K, OSHIRO S, TOZAWA M, et al: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24:691-697, 2001
8. MESSERLI FH, FROHLICH ED, DRESLINSKI GR, et al: Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med 93:817-821, 1980
9. SESOKO S, PEGRAM BL, WILLIS GW, FROHLICH ED: DOCA-salt induced malignant hypertension in spontaneously hypertensive rats. J Hypertens 2:49-54, 1984
10. WU X, WAKAMIYA M, VAISHNAV S, et al: Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci USA 91:742-746, 1994
11. WAISMAN J, MWASI LM, BLUESTONE R, et al: Acute hyperuricemic nephropathy in rats. An electron microscopic study. Am J Pathol 81:367-378, 1975
12. MAZZALI M, KANELLIS J, HAN L, et al: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-F997, 2002
13. MAZZALI M, HUGHES J, KIM YG, et al: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101-1106, 2001
14. MAZZALI M, KIM YG, SUGA S, et al: Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 71:900-905, 2001
15. SANCHEZ-LOZADA LG, TAPIA E, AVILA-CASADO C, et al: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283:F1105-F1110, 2002
16. SCHOR N, ICHIKAWA I, BRENNER BM: Glomerular adaptations to chronic dietary salt restriction or excess. Am J Physiol 238:F428-F436, 1980
17. KANG DH, NAKAGAWA T, FENG L, et al: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888-2897, 2002
18. DAVIDSON WD, SACKNER MA: Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 62:351-356, 1963
19. VUREK GG, PEGRAM SE: Fluorometric method for the determination of nanogram quantities of inulin. Ann Biochem 16:409-419, 1966
20. BAYLIS C, DEEN WM, MYERS BD, BRENNER BM: Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 230:1148-1158, 1976
21. VIETS JW, DEEN WM, TROY JL, BRENNER BM: Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem 88:513-521, 1978
22. HENRY RJ, SOBEL CH, SEGALOVE M: Turbidimetric determination of proteins with sulfosalicylic and trichloroacetic acids. Proc Soc Exp Biol Med 92:748-751, 1956
23. QUIROZ Y, PONS H, GORDON KL, et al: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281:F38-47, 2001
24. SKOV K, MULVANY MJ, KORSGAARD N: Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 20:821-827, 1992
25. CLAPP WL, CROKER BP: Adult kidney, in Histology for Pathologists, 2nd ed., edited by Sternberg SS, Philadelphia, PA, Lippincott-Raven, 1997, pp 799-834
26. RINCON J, PARRA G, QUIROZ Y, et al: Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness. Clin Exp Immunol 121:391-398, 2000
27. TAPIA E, FRANCO M, SANCHEZ-LOZADA LG, et al: Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 63:994-1002, 2003
28. RAO GN, CORSON MA, BERK BC: Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266:8604-8608, 1991
29. BOBADILLA NA, TACK I, TAPIA E, et al: Pentosan polysulfate prevents glomerular hypertension and structural injury despite persisting hypertension in 5/6 nephrectomy rats. J Am Soc Nephrol 12:2080-2087, 2001
30. KOMATSU K, FROHLICH ED, ONO H, et al: Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Hypertension 25:207-213, 1995
31. SIMONS JL, PROVOOST AP, ANDERSON S, et al: Modulation of hypertension defines susceptibility to progressive glomerular injury. Kidney Int 46:396-404, 1994
32. TOUYZ RM, HE G, EL MABROUK M, SCHIFFRIN EL: p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 37:574-580, 2001
33. NAKAGAWA T, MAZZALI M, KANG D-H, et al: Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 23:2-7, 2003
34. JOHNSON RJ, HERRERA-ACOSTA J, SCHREINER GF, RODRIGUEZ-ITURBE B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346:913-923, 2002
35. KANG DH, NAKAGAWA T, FENG L, JOHNSON RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161:239-248, 2002
36. BOHLE A, MACKENSEN-HAEN S, WEHRMANN M: Significance of post-glomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19:191-195, 1996
37. WATANABE S, KANG DH, FENG L, et al: Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 40:355-360, 2002
38. RATSCHEK M, RATSCHEK E, BOHLE A: Decompensated benign nephrosclerosis and secondary malignant nephrosclerosis. Clin Nephrol 25:221-226, 1986